Advertisement

Journal of Neural Transmission

, Volume 70, Issue 1–2, pp 169–173 | Cite as

Effects of oral aspartame on plasma phenylalanine in humans and experimental rodents

  • R. J. Wurtman
  • T. J. Maher
Short Note

Summary

All aspartame does given to humans cause greater elevations in plasma (and, presumably, brain) phenylalanine than in plasma tyrosine. In contrast, doses of aspartame usually used in experiments on rodents preferentially elevate tyrosine. Since phenylalanine can inhibit brain catecholamine synthesis while tyrosine is the antidote for this effect, we determined the aspartame dose that would be needed to elevate phenylalanine more than tyrosine in rodents, using published data. In general rodents need 60 times as much aspartame, on a mg/kg basis, as humans to obtain comparable elevations in phenylalanine with respect to tyrosine.

Key words

Aspartame phenylalanine tyrosine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bradstock MK, Serdula MK, Marks JS, Barnard RJ, Crane NT, Remmington PL, Trowbridge FL (1986) Evaluation of reactions to food additives: the aspartame experience. Am J Clin Nutr 43: 464–469PubMedGoogle Scholar
  2. Caballero B, Mahon B, Rohr F, Levy HL, Wurtman RJ (1986) Plasma amino acid levels after single dose aspartame consumption in phenylketonuria. J Pediatr 109: 669–671Google Scholar
  3. Department of Health and Human Services. Quarterly Report on adverse reactions associated with aspartame ingestion. October 1, 1986Google Scholar
  4. Drake ME (1986) Panic attacks and excessive aspartame ingestion. Lancet ii: 631Google Scholar
  5. Garratini S (1986) Aspartame, brain monoamines and neurochemical mediators. International Aspartame Workshop, Nov. 17–21, 1986, Marbella, SpainGoogle Scholar
  6. Johns D (1986) Migraine provoked by aspartame. N Engl J Med 315: 456Google Scholar
  7. Kiritsy PJ, Maher TJ (1986) Acute effects of aspartame on systolic blood pressure in spontaneously hypertensive rats. J Neural Transm 66: 121–128PubMedGoogle Scholar
  8. Maher TJ, Pinto JMB (1987) Aspartame administration potentiates fluorothyl-induced seizures in mice. J Neurochem 48: S52Google Scholar
  9. Milner JD, Wurtman RJ (1985) Tyrosine availability determines stimulus-evoked dopamine release from rat striatal slices. Neurosci Lett 59: 215–220PubMedGoogle Scholar
  10. Milner JD, Irie K, Wurtman RJ (1986) Effects of phenylalanine on the release of endogenous dopamine from rat striatal slices of endogenous dopamine from rat striatal slices. J Neurochem 47: 1444–1448PubMedGoogle Scholar
  11. Pardridge WM (1986) Potential effects of the dipeptide sweetener aspartame on the brain. In: Wurtman RJ, Wurtman JJ (eds) Nutrition and the brain. Raven Press, New York 7: 199–241Google Scholar
  12. Pinto JMB, Maher TJ (1986) High dose aspartame lowers the seizure threshold to subcutaneous pentylenetetrazole in mice. Pharmacologist 28: 201Google Scholar
  13. Stegink LD, Filer LJ jr, Baker GL, McDonnell JE (1979 a) Effect of aspartame loading upon plasma and erythrocyte amino acid levels in phenylketonuric heterozygotes and normal adult subjects. J Nutr 109: 708–717PubMedGoogle Scholar
  14. Stegink LD, Filer LJ jr, Baker GL (1979 b) Plasma, erythrocyte and human milk levels of free amino acids in lactating women administered aspartame or lactose. J Nutr 109: 2173–2181PubMedGoogle Scholar
  15. Stegink LD, Filer LJ jr, Baker GL, McDonnell JE (1980) Effect of an abuse dose of aspartame upon plasma and erythrocyte levels of amino acids in phenylketonuric heterozygous and normal adults. J Nutr 110: 2216–2224PubMedGoogle Scholar
  16. Stegink LD (1984) Aspartame metabolism in humans: acute dosing studies. In: Stegink LD, Filer LJ (eds) Aspartame: physiology and biochemistry. Marcel Dekker, New York, pp 509–553Google Scholar
  17. Swaiman KF (1969) The effect of phenylalanine and its metabolites on glucose utilization in developing brain. J Neurochem 16: 385–388PubMedGoogle Scholar
  18. Wurtman RJ (1983) Neurochemical changes following high-dose aspartame with dietary carbohydrates. N Engl J Med 309: 429–430PubMedGoogle Scholar
  19. Wurtman RJ (1985) Aspartame: possible effect on seizure susceptibility. Lancet: 1060Google Scholar
  20. Yokogoshi H, Roberts CH, Caballero B, Wurtman RJ (1984) Effects of aspartame and glucose administration on brain and plasma levels of large neutral amino acids and brain 5-hydroxyindoles. Am J Clin Nutr 40: 1–7PubMedGoogle Scholar
  21. Yokogoshi H, Wurtman RJ (1986) Acute effects of oral or parenteral aspartame on catecholamine metabolism in various regions of rat brain. J Nutr 116: 356–364PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • R. J. Wurtman
    • 1
  • T. J. Maher
    • 2
  1. 1.Massachusetts Institute of TechnologyCambridge
  2. 2.Massachusetts College of PharmacyBostonUSA

Personalised recommendations